Global Peripheral Artery Disease (PAD) Market: Trends & Opportunities (2015-2020)
Scope of the Report
This report entitled “Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020)”, analyses the global market for peripheral artery disease and the treatments available for it. The global peripheral artery disease market is analyzed by value, by number of people affected from PAD, PAD by prevalence, by treatment mix and by players in this market. This report also includes forecasting of peripheral artery disease market by value and by number of people affected for the years 2015-2020. The sizing and growth of global peripheral atherectomy market is provided in this report, which includes PAD atherectomy market by value and by players. The forecasting of PAD atherectomy market by value is also provided for the years 2015-2020.
This report includes the analysis of global peripheral artery disease device market by value and by product types. This segment of report also includes the sizing and growth of global PAD angioplasty market and global PAD stent market, with focus on drug coated balloons (DCB) market and drug eluting stents (DES) market.
Furthermore, this report also provides the analysis of United States’ peripheral artery disease market. The analysis includes the US PAD market by value and by treatment mix. This segment of report also includes the US PAD atherectomy market by value and by players and the US PAD drug coated balloons (DCB) market by value and by players.
Global peripheral artery disease market dynamics are also given in this report which includes the growth drivers, market trends and challenges faced by this market. Company profiling of three major players (Johnson & Johnson, Medtronic Inc. and Stryker Corporation) of peripheral artery disease market is done in this report. Company profiling includes business overview, financial overview and business strategies of each company.
Country Coverage
Peripheral artery disease (PAD) is a medical condition in which arteries become narrow due to build-up of plague on the vessel walls. Peripheral artery disease affects the arteries of arms, legs or neuro-vasculature, other than those that supply the heart and brain.
Peripheral artery disease is also known as Peripheral Vascular Disease (PVD) and Peripheral Artery Occlusive Disease. Plaque that deposits in the arteries is made up of fats, cholesterol, calcium, fibrous tissue and other substances in the blood. Plaque formations can grow large enough to significantly reduce the blood's flow through an artery.
Treatment of Peripheral artery disease requires multiple approaches, depending on the individual patient. There are two main approaches for the treatment of PAD. The first approach is endovascular treatment, which includes stenting, ballooning and atherectomy. These different treatments can also be used in combination, such as atherectomy with stenting. The second approach is surgical treatment, which includes bypass surgery and amputation.
The global peripheral artery disease market has increased with a healthy growth rate in 2014 and is expected to increase further in coming years. The main driving forces for PAD market are increasing population, especially the age group of 65 and above, rising global healthcare expenditure, technological advancements and favorable reimbursement rates for PAD treatment. Yet there are some challenges which PAD industry faces such as restenosis (re-occurrence of PAD post treatment), inappropriate diagnosis and limitations of existing devices.
This report entitled “Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020)”, analyses the global market for peripheral artery disease and the treatments available for it. The global peripheral artery disease market is analyzed by value, by number of people affected from PAD, PAD by prevalence, by treatment mix and by players in this market. This report also includes forecasting of peripheral artery disease market by value and by number of people affected for the years 2015-2020. The sizing and growth of global peripheral atherectomy market is provided in this report, which includes PAD atherectomy market by value and by players. The forecasting of PAD atherectomy market by value is also provided for the years 2015-2020.
This report includes the analysis of global peripheral artery disease device market by value and by product types. This segment of report also includes the sizing and growth of global PAD angioplasty market and global PAD stent market, with focus on drug coated balloons (DCB) market and drug eluting stents (DES) market.
Furthermore, this report also provides the analysis of United States’ peripheral artery disease market. The analysis includes the US PAD market by value and by treatment mix. This segment of report also includes the US PAD atherectomy market by value and by players and the US PAD drug coated balloons (DCB) market by value and by players.
Global peripheral artery disease market dynamics are also given in this report which includes the growth drivers, market trends and challenges faced by this market. Company profiling of three major players (Johnson & Johnson, Medtronic Inc. and Stryker Corporation) of peripheral artery disease market is done in this report. Company profiling includes business overview, financial overview and business strategies of each company.
Country Coverage
- United States
- Johnson & Johnson
- Medtronic Inc.
- Stryker Corporation
Peripheral artery disease (PAD) is a medical condition in which arteries become narrow due to build-up of plague on the vessel walls. Peripheral artery disease affects the arteries of arms, legs or neuro-vasculature, other than those that supply the heart and brain.
Peripheral artery disease is also known as Peripheral Vascular Disease (PVD) and Peripheral Artery Occlusive Disease. Plaque that deposits in the arteries is made up of fats, cholesterol, calcium, fibrous tissue and other substances in the blood. Plaque formations can grow large enough to significantly reduce the blood's flow through an artery.
Treatment of Peripheral artery disease requires multiple approaches, depending on the individual patient. There are two main approaches for the treatment of PAD. The first approach is endovascular treatment, which includes stenting, ballooning and atherectomy. These different treatments can also be used in combination, such as atherectomy with stenting. The second approach is surgical treatment, which includes bypass surgery and amputation.
The global peripheral artery disease market has increased with a healthy growth rate in 2014 and is expected to increase further in coming years. The main driving forces for PAD market are increasing population, especially the age group of 65 and above, rising global healthcare expenditure, technological advancements and favorable reimbursement rates for PAD treatment. Yet there are some challenges which PAD industry faces such as restenosis (re-occurrence of PAD post treatment), inappropriate diagnosis and limitations of existing devices.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Causes of Peripheral Artery Disease
2.1.1 Risk Factors for Peripheral Artery Disease
2.2 Symptoms of Peripheral Artery Disease
2.3 Diagnosis of Peripheral Artery Disease
2.4 Treatment of Peripheral Artery Disease
2.4.1 Percutaneous Transluminal Angioplasty (PTA)
2.4.2 Stents
2.4.3 Arterial Bypass
2.4.4 Atherectomy
2.4.5 Amputation
3. GLOBAL PERIPHERAL ARTERY DISEASE MARKET ANALYSIS
3.1 Global Peripheral Artery Disease Market: An Analysis
3.1.1 Global Peripheral Artery Disease Market by Value
3.1.2 Global Peripheral Artery Disease Market by Number of People Affected
3.1.3 Global Peripheral Artery Disease Market by Prevalence
3.1.4 Global Peripheral Artery Disease Market by Treatment Mix
3.1.5 Global Peripheral Artery Disease Market Share by Players
3.2 Global PAD Atherectomy Market: Sizing and Growth
3.2.1 Global PAD Atherectomy Market by Value
3.2.2 Global PAD Atherectomy Market Share by Players
4. GLOBAL PERIPHERAL ARTERY DISEASE DEVICE MARKET: AN ANALYSIS
4.1 Global Peripheral Artery Disease Device Market: Sizing and Growth
4.1.1 Global PAD Device Market by Value
4.1.2 Global PAD Device Market by Products
4.2 Global PAD Angioplasty Balloon Market: Sizing and Growth
4.2.1 Global PAD Angioplasty Market by Type
4.2.2 Global PAD Drug Coated Balloon (DCB) Market
4.3 Global PAD Stent Market: Sizing and Growth
4.3.1 Global PAD Stent Market Share by Players
4.3.2 Drug Eluted Stents (DES) Pricing Trends by Geography
4.3.3 Drug Eluted Stents (DES) Estimated Volume Trends by Geography
5. REGIONAL/COUNTRY ANALYSIS
5.1 US Peripheral Artery Disease Market: An Analysis
5.1.1 US PAD Market by Volume
5.1.2 US PAD Market by Treatment Mix
5.1.3 US PAD Atherectomy Market
5.1.4 US PAD Drug Coated Balloon (DCB) Market
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 PAD Increases with Age
6.1.2 Rising Global Healthcare Expenditure
6.1.3 Growing Cases for Obesity
6.1.4 Increase in Global Diabetic Population
6.1.5 Favorable Reimbursement Rates
6.2 Challenges
6.2.1 Limitation of Balloon/Stents
6.2.2 In-Stent Restenosis
6.2.3 Inappropriate Diagnostics
6.3 Market Trends
6.3.1 Shift from bypass surgeries to less invasive treatments
6.3.2 Drug Eluting Balloons
6.3.3 Imaging in Endovascular Treatment
7. COMPETITIVE LANDSCAPE
8. COMPANY PROFILES
8.1 Johnson & Johnson (Cordis Corporation)
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Medtronic Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Stryker Corporation
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
2. INTRODUCTION
2.1 Causes of Peripheral Artery Disease
2.1.1 Risk Factors for Peripheral Artery Disease
2.2 Symptoms of Peripheral Artery Disease
2.3 Diagnosis of Peripheral Artery Disease
2.4 Treatment of Peripheral Artery Disease
2.4.1 Percutaneous Transluminal Angioplasty (PTA)
2.4.2 Stents
2.4.3 Arterial Bypass
2.4.4 Atherectomy
2.4.5 Amputation
3. GLOBAL PERIPHERAL ARTERY DISEASE MARKET ANALYSIS
3.1 Global Peripheral Artery Disease Market: An Analysis
3.1.1 Global Peripheral Artery Disease Market by Value
3.1.2 Global Peripheral Artery Disease Market by Number of People Affected
3.1.3 Global Peripheral Artery Disease Market by Prevalence
3.1.4 Global Peripheral Artery Disease Market by Treatment Mix
3.1.5 Global Peripheral Artery Disease Market Share by Players
3.2 Global PAD Atherectomy Market: Sizing and Growth
3.2.1 Global PAD Atherectomy Market by Value
3.2.2 Global PAD Atherectomy Market Share by Players
4. GLOBAL PERIPHERAL ARTERY DISEASE DEVICE MARKET: AN ANALYSIS
4.1 Global Peripheral Artery Disease Device Market: Sizing and Growth
4.1.1 Global PAD Device Market by Value
4.1.2 Global PAD Device Market by Products
4.2 Global PAD Angioplasty Balloon Market: Sizing and Growth
4.2.1 Global PAD Angioplasty Market by Type
4.2.2 Global PAD Drug Coated Balloon (DCB) Market
4.3 Global PAD Stent Market: Sizing and Growth
4.3.1 Global PAD Stent Market Share by Players
4.3.2 Drug Eluted Stents (DES) Pricing Trends by Geography
4.3.3 Drug Eluted Stents (DES) Estimated Volume Trends by Geography
5. REGIONAL/COUNTRY ANALYSIS
5.1 US Peripheral Artery Disease Market: An Analysis
5.1.1 US PAD Market by Volume
5.1.2 US PAD Market by Treatment Mix
5.1.3 US PAD Atherectomy Market
5.1.4 US PAD Drug Coated Balloon (DCB) Market
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 PAD Increases with Age
6.1.2 Rising Global Healthcare Expenditure
6.1.3 Growing Cases for Obesity
6.1.4 Increase in Global Diabetic Population
6.1.5 Favorable Reimbursement Rates
6.2 Challenges
6.2.1 Limitation of Balloon/Stents
6.2.2 In-Stent Restenosis
6.2.3 Inappropriate Diagnostics
6.3 Market Trends
6.3.1 Shift from bypass surgeries to less invasive treatments
6.3.2 Drug Eluting Balloons
6.3.3 Imaging in Endovascular Treatment
7. COMPETITIVE LANDSCAPE
8. COMPANY PROFILES
8.1 Johnson & Johnson (Cordis Corporation)
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Medtronic Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Stryker Corporation
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
TABLE OF FIGURES
Figure 1: Risk Factors for Peripheral Artery Disease
Figure 2: Diagnosis of Peripheral Artery Disease
Figure 3: Peripheral Artery Disease by Treatment
Figure 4: Global Peripheral Artery Disease Market by Value; 2006-2014 (US$ Billion)
Figure 5: Global Peripheral Artery Disease Market by Value; 2015-2020 (US$ Billion)
Figure 6: Global Peripheral Artery Disease Market by Number of People Affected; 2010-2014 (Million)
Figure 7: Global Peripheral Artery Disease Market by Number of People Affected; 2015-2020 (Million)
Figure 8: Global Peripheral Artery Disease Market by Prevalence; 2014
Figure 9: Global Peripheral Artery Disease Market by Treatment Mix; 2014
Figure 10: Global Peripheral Artery Disease Market Share by Players; 2014
Figure 11: Global PAD Atherectomy Market by Value; 2012-2020 (US$ Million)
Figure 12: Global PAD Atherectomy Market Share by Players; 2014
Figure 13: Global PAD Device Market by Value; 2014-2020 (US$ Billion)
Figure 14: Global PAD Device Market by Products; 2014
Figure 15: Global PAD Angioplasty Market by Type; 2014 (US$ Million)
Figure 16: Global PAD Drug Coated Balloon Market by Value; 2014-2020 (US$ Million)
Figure 17: Global PAD Drug Coated Balloon Market by Players; 2020
Figure 18: Global PAD Stent Market Share by Players; 2014
Figure 19: Drug Eluted Stents (DES) Pricing Trends by Geography; 2010-2014 (US$)
Figure 20: Drug Eluted Stents (DES) Estimated Volume Trends by Geography; 2010-2014 (Million Units)
Figure 21: US PAD Market by Volume; 2012-2015 (Million)
Figure 22: US PAD Market by Diagnosed Cases and PAD Interventions; 2012-2015 (Million)
Figure 23: US PAD Market by Number of Atherectomy Procedures; 2012-2015 (Thousand)
Figure 24: US PAD Market by Treatment Mix; 2014
Figure 25: US PAD Atherectomy Market by Value; 2012-2015 (US$ Million)
Figure 26: US PAD Atherectomy Market by Value; 2016-2020 (US$ Million)
Figure 27: US PAD Atherectomy Market by Players; 2014
Figure 28: US PAD Drug Coated Balloon (DCB) Market by Value; 2015-2020 (US$ Million)
Figure 29: US PAD Drug Coated Balloon (DCB) Market by Players; 2015-2017
Figure 30: PAD Prevalence by Age Group; 2014
Figure 31: World Population; 2009-2014 (Billion)
Figure 32: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 33: Global Obese Population; 2009-2014 (Million)
Figure 34: Global Diabetic Population; 2009-2014 (Million)
Figure 35: PAD Reimbursement Rates; 2013-2014 (Percentage Change)
Figure 36: Market Share of Major Players in Global Peripheral Artery Disease Market; 2010-2014
Figure 37: Johnson & Johnson Revenue; 2010-2014 (US$ Billion)
Figure 38: Johnson & Johnson Revenue; 2014
Figure 39: Johnson & Johnson Revenue by Region; 2014
Figure 40: Medtronic Revenue; 2011-2014 (US$ Billion)
Figure 41: Medtronic Revenue by Segments; 2015
Figure 42: Medtronic Revenue by Region; 2015
Figure 43: Stryker Revenue; 2010-2014 (US$ Billion)
Figure 44: Stryker Revenue by Segments; 2014
Figure 45: Stryker Revenue by Region; 2014
Table 1: US Atherectomy Market Overview by Players
Table 2: Financial Comparison of Major Players in Global Peripheral Artery Disease Market; 2014 (US$ Billion)
Table 3: US Peripheral Artery Disease Market by Players’ Product Portfolio
Figure 1: Risk Factors for Peripheral Artery Disease
Figure 2: Diagnosis of Peripheral Artery Disease
Figure 3: Peripheral Artery Disease by Treatment
Figure 4: Global Peripheral Artery Disease Market by Value; 2006-2014 (US$ Billion)
Figure 5: Global Peripheral Artery Disease Market by Value; 2015-2020 (US$ Billion)
Figure 6: Global Peripheral Artery Disease Market by Number of People Affected; 2010-2014 (Million)
Figure 7: Global Peripheral Artery Disease Market by Number of People Affected; 2015-2020 (Million)
Figure 8: Global Peripheral Artery Disease Market by Prevalence; 2014
Figure 9: Global Peripheral Artery Disease Market by Treatment Mix; 2014
Figure 10: Global Peripheral Artery Disease Market Share by Players; 2014
Figure 11: Global PAD Atherectomy Market by Value; 2012-2020 (US$ Million)
Figure 12: Global PAD Atherectomy Market Share by Players; 2014
Figure 13: Global PAD Device Market by Value; 2014-2020 (US$ Billion)
Figure 14: Global PAD Device Market by Products; 2014
Figure 15: Global PAD Angioplasty Market by Type; 2014 (US$ Million)
Figure 16: Global PAD Drug Coated Balloon Market by Value; 2014-2020 (US$ Million)
Figure 17: Global PAD Drug Coated Balloon Market by Players; 2020
Figure 18: Global PAD Stent Market Share by Players; 2014
Figure 19: Drug Eluted Stents (DES) Pricing Trends by Geography; 2010-2014 (US$)
Figure 20: Drug Eluted Stents (DES) Estimated Volume Trends by Geography; 2010-2014 (Million Units)
Figure 21: US PAD Market by Volume; 2012-2015 (Million)
Figure 22: US PAD Market by Diagnosed Cases and PAD Interventions; 2012-2015 (Million)
Figure 23: US PAD Market by Number of Atherectomy Procedures; 2012-2015 (Thousand)
Figure 24: US PAD Market by Treatment Mix; 2014
Figure 25: US PAD Atherectomy Market by Value; 2012-2015 (US$ Million)
Figure 26: US PAD Atherectomy Market by Value; 2016-2020 (US$ Million)
Figure 27: US PAD Atherectomy Market by Players; 2014
Figure 28: US PAD Drug Coated Balloon (DCB) Market by Value; 2015-2020 (US$ Million)
Figure 29: US PAD Drug Coated Balloon (DCB) Market by Players; 2015-2017
Figure 30: PAD Prevalence by Age Group; 2014
Figure 31: World Population; 2009-2014 (Billion)
Figure 32: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 33: Global Obese Population; 2009-2014 (Million)
Figure 34: Global Diabetic Population; 2009-2014 (Million)
Figure 35: PAD Reimbursement Rates; 2013-2014 (Percentage Change)
Figure 36: Market Share of Major Players in Global Peripheral Artery Disease Market; 2010-2014
Figure 37: Johnson & Johnson Revenue; 2010-2014 (US$ Billion)
Figure 38: Johnson & Johnson Revenue; 2014
Figure 39: Johnson & Johnson Revenue by Region; 2014
Figure 40: Medtronic Revenue; 2011-2014 (US$ Billion)
Figure 41: Medtronic Revenue by Segments; 2015
Figure 42: Medtronic Revenue by Region; 2015
Figure 43: Stryker Revenue; 2010-2014 (US$ Billion)
Figure 44: Stryker Revenue by Segments; 2014
Figure 45: Stryker Revenue by Region; 2014
Table 1: US Atherectomy Market Overview by Players
Table 2: Financial Comparison of Major Players in Global Peripheral Artery Disease Market; 2014 (US$ Billion)
Table 3: US Peripheral Artery Disease Market by Players’ Product Portfolio
